Background:

The Food and Drug Administration, Center for Tobacco Products (CTP), has articulated research priorities that include the identification of in vitro models and assays for assessing tobacco constituent or compound hazards, and for comparing the respiratory toxicity of different tobacco products.  The Institute for In Vitro Sciences (IIVS), a non-profit laboratory, has a mission to promote the use and regulatory acceptance of in vitro methods. With its experience in working collaboratively to optimize and validate in vitro methods, IIVS designed this workshop to bring together a consortium of experts and participants to specifically address the CTP's relevant research goals. 

Areas to be explored in the workshop include:

• Inflammation and Oxidative Stress
• Ciliary Dysfunction and Ion Transport
• Goblet Cell Hyperplasia and Mucus Production
• Parenchymal/Bronchial Tissue Destruction and Remodeling

Click Here to View Agenda

We encourage attendance and active participation from stakeholders and scientists within government, academia, industry, and in vitro/ex vivo model development. 

Funding for this conference was made possible, in part, by the Food and Drug Administration through grant 1 R13 FD 005299 - 01. Views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Humans Services; nor does any mention of the trade names, commercial practices or organization imply endorsement by the United States Government.”

Register Now!Deadline for Registration is November 21st.  Deadline to receive discounted hotel room rates is November 14.

Posters:

If you are interested in presenting a poster at the workshop please contact Dr. Holger Behrsing at hbehrsing@iivs.org. For more information and guidance on how to submit a poster, please click here.